Log in
Enquire now
‌

US Patent 10093686 Heteroaryl inhibitors of PDE4

Patent 10093686 was granted and assigned to Tetra Therapeutics on October, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Tetra Therapeutics
Tetra Therapeutics
Current Assignee
Tetra Therapeutics
Tetra Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10093686
Patent Inventor Names
Timothy J. Hagen0
Mark E. Gurney0
Robert F. Campbell0
Xuesheng Mo0
A. Samuel Vellekoop0
Donna L. Romero0
Joel R. Walker0
Lei Zhu0
Date of Patent
October 9, 2018
Patent Application Number
15680842
Date Filed
August 18, 2017
Patent Citations Received
‌
US Patent 11401286 Heteroaryl inhibitors of PDE4
0
‌
US Patent 10364258 Heteroaryl inhibitors of PDE4
0
‌
US Patent 10626129 Heteroaryl inhibitors of PDE4
‌
US Patent 11767334 Heteroaryl inhibitors of PDE4
Patent Primary Examiner
‌
Deepak R Rao
Patent abstract

The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10093686 Heteroaryl inhibitors of PDE4

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.